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Cardiovascular effects of high intensity aerobic interval training 
in hypertensive patients, healthy aged and young persons 
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Sammendrag 
 
I denne oppgaven ble det undersøkt effekter av høyintensiv aerob intervall trening (AIT) blant 
personer med høyt blodtrykk og blant friske eldre og yngre personer.   
AIT med høy intensitet (>90% av maksimal puls) er mer effektiv for å øke kondisjonen og 
redusere risikofaktorer for hjerte- karsykdom sammenlignet med trening ved moderat intensitet (-
70% av maksimal puls). Dette er tidligere vist blant friske personer og pasienter med hjertesvikt, 
angina pectoris og metabolsk syndrom.  
Høyt blodtrykk (hypertensjon) er en viktig risikofaktor for hjerneslag, hjerteinfarkt og 
hjertesvikt., ansvarlig for 7 millioner dødsfall pr. år på verdensbasis. Om lag 30 % av den voksne 
befolkningen har høyt blodtrykk. 
I den første studien undersøkte vi effekten av trening ved høyt blodtrykk. AIT ble sammenlignet 
med en gruppe som trente ved moderat intensitet (MIT) og en kontrollgruppe. Begge 
treningsgruppene trente på tredemølle, 3 ganger per uke i 12 uker.  Kontrollgruppen fikk 
standardiserte treningsråd, men ingen veiledet trening. Resultatene viste at begge treningsformer 
reduserte 24 timers blodtrykk og forbedret den systoliske (hjertets evne til å pumpe blod) 
hjertefunksjonen, men at AIT var mer effektiv til å senke systolisk blodtrykk (overtrykket), øke 
kondisjonen, forbedre kolesterolet og forbedre den diastoliske (hjertets evne til å fylle seg mellom 
hjerteslagene) hjertefunksjonen.  
I den andre studien trente friske eldre (>70 år) AIT 3 ganger per uke i 12 uker, og kondisjonen ble 
forbedret med 15 % (lik relativ økning som vist hos yngre personer). Resultatene ble 
sammenlignet med yngre friske personer og eldre (> 70 år) toppatleter (Birkebeinerresultat). Den 
diastoliske hjertefunksjonen ble forbedret til samme nivå som de eldre toppatletene, men den var 
fortsatt svært redusert sammenlignet med yngre personer.  Hjertet til de eldre ble kraftigere og 
større etter treningen, men var fortsatt mindre enn hos de eldre toppatletene.  
I den tredje studien ønsket vi å undersøke hvilken treningsfrekvens som var best for å øke 
kondisjonen, lungefunksjonen og hjertefunksjonen. Friske unge personer ble enten satt til å trene 
AIT 3 ganger per uke i 8 uker (moderat frekvens gruppen, MF) eller 8 ganger per uke i 3 uker 
(høyfrekvensgruppen, HF).  Begge treningsperioder ble etterfulgt av en detreningsperiode uten 
trening i 8 uker. MF gruppen økte kondisjonen, lungefunksjonen og hjertefunksjonen progressivt 
under treningen og denne gikk gradvis tilbake under detreningen. HF gruppen fikk i 
utgangspunktet en tendens til nedgang i kondisjonen og en signfikant nedgang i lungefunksjon og 
hjertefunksjon. Dette normaliserte seg etter detreningsperioden.  
Konklusjonen på oppgaven er at høyintensiv aerob intervall trening er en trygg og effektiv 
metode for å øke kondisjonen, forbedre hjertefunksjonen og senke blodtrykket hos personer med 
høyt blodtrykk og blant friske eldre og yngre personer. For å unngå overtrening bør utrente 
personer trene med moderat frekvens, slik at kroppen får restituert seg mellom treningsøktene.  
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Definitions 
Physical activity: Any bodily movement produced by the skeletal muscles resulting in a 
substantial increase over the resting energy expenditure 
 
Exercise: A physical activity which is planned, repetitive, structured and purposeful in 
the sense that improvement or maintenance of physical fitness is the objective. 
 
Physical fitness: set of attributes that people have or try to achieve, related to the ability 
to perform physical activity, such as cardiorespiratory fitness, muscle strength, body 
composition, and flexibility. The term fitness is associated by a state of physiological 
well being. This approach can be health related, allowing one to meet the demands of 
daily life challenges, or it can be performance-related in providing the basis for sports 
activities. 
 
Aerobic capacity: 
Aerobic capacity is normally influenced by three different factors; VO2max, lactate 
threshold and work economy  
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Introduction 
The association between physical activity, health and longevity has been known for 
centuries. More than 2500 years ago Hippocrates  stated that: “Speaking generally, all 
parts of the body which have a function, if used in moderation and exercised in labors to 
which each is accustomed, become thereby healthy and well developed and age slowly; 
but if unused and left idle, they become liable to disease, defective in growth, and age 
quickly”. 
 
The relation between regular physical activity and fitness status to both cardiovascular 
and all cause mortality is strong, independent, inverse and graded (1-6). Cardiovascular 
diseases (CVD) are the leading causes of death, counting for every third death worldwide 
(7). In industrialized countries the rate is higher, 49% of all deaths in Europe (8) and 
about 39 % in Norway (9). Physical fitness has been commonly accepted as one of the 
strongest associates of mortality reduction, compared to other known risk factors such as 
smoking, hypertension, elevated cholesterol, obesity and diabetes type 2 (10, 11). 
Moreover, there is evidence that physical active subjects have reduced risk of other 
chronic conditions, such as cardiovascular diseases (CVD), osteoporosis, some cancers 
(breast, colon) and dementia (2, 12). In addition, increased physical activity is associated 
with higher well-being and reduced risk of psychiatric disorders, such as depression and 
anxiety (2).  
 
The relation between CVD risk reduction and physical activity has shown a clear dose-
response pattern with continuously lower risk at higher levels of regular physical activity, 
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resulting in to a improved protection for the fit and the most active subjects (4, 13). This 
robust and independent association is apparent in healthy people and people with CVD, 
and is observed in youth, middle-aged and elderly populations (2, 14). Physical fitness is 
modifiable and physical activity improves fitness which is associated with reduced 
mortality from all-causes, and specifically, from CVD (15, 16). This association is 
independent of genetic factors (17). In patients with CVD, randomized studies have 
shown reduced risk  with training (18). In healthy persons, there are no sufficiently large 
scale randomized studies showing definite risk reduction with increased physical activity, 
the evidence is still limited to surrogate end points and epidemiological associations. 
Additionally, there is evidence that heritability may influence the training response up to 
~50% (19), and that the responsiveness to training may influence the effect on risk 
factors (20). 
 
Physical activity 
The profile of physical activity can be varied by different mode, frequency, intensity and 
duration. To define the amount of physical activity there exist an interrelation between 
dose and intensity of the activity. The dose of physical activity refers to the amount of 
energy used during physical activity, often measured as total amount of calories. Intensity 
reflects the rate of energy expenditure, either measured as absolute intensity, often 
measured as oxygen uptake, or relative intensity, referring to the percentage of maximal 
aerobic power during exercise expressed as percentage of maximal HR or VO2max. 
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Maximal Oxygen Uptake (VO2max) 
VO2max is considered as the best measure of cardio-respiratory fitness, and refers to the 
maximum capacity of an individual's body to transport and use oxygen during 
incremental exercise (21). It is either expressed as an absolute rate in liters (volume) of 
oxygen per minute (L/min) or as a relative rate in milliliters of oxygen per kilogram of 
bodyweight per minute (ml/kg/min). The main factors that influence VO2max are cardiac 
output reserve (COmax) and the maximal arterio venous (a-vO2) difference, i.e. the 
maximal extraction. This is defined by Ficks equation: 
 
VO2max = COmax x avO2diff max  
VO2max = SVmax x HRmax x avO2diff max 
 
Every part of the oxygen supply transport chain, from the lungs to the mitochondria may 
affect the VO2max. Although it has been debated, it is generally accepted that the main 
limiting factor of VO2max in healthy subjects, is the ability of the cardio-respiratory 
system to deliver oxygen to the working musculatures (21, 22). Arterio-venous extraction 
is not higher in endurance trained athletes than sedentary controls (23). Since maximal 
heart rate (HRmax) is barely influenced by fitness status or physical activity level (24), SV 
is the main determinant of training induced increase in fitness. However, peripheral 
mitochondrial capacity is usually down regulated to match the central capacity in 
individuals with low fitness. Thus the limitation may be both central and peripheral (25).  
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Aging affects the aerobic capacity and a decline in VO2max by about 10% per decade has 
been observed in the population after 30 years of age (23). The rate of decline seems to 
be independent of physical activity level, although individuals with high activity level has 
higher absolute VO2max (26).  
 
Resting heart rate and Heart Rate Recovery (HRR) 
Resting HR correlates with mortality (27, 28). Regular physical activity and increased 
fitness level lowers resting HR (21). The mechanisms are not fully understood, but a 
regulation in the autonomic nervous system from a sympathetic to a more 
parasympathetic dominance is believed to occur (29). In addition, the myocardial SV 
increases and a lower HR is thus needed to maintain a sufficient CO. HR reserve (HRmax 
– HR rest) increases as HRmax changes minimally by training.   
 
Heart rate recovery (HRR) is the decline in HR after cessation of a maximal exercise test, 
and refers to the difference in HR between HRmax and at one, and –or two minutes after 
terminating the test (30, 31). HRR is a predictor of mortality in both healthy individuals 
and patients referred to exercise testing (30, 31). Regular physical activity and increased 
fitness level increase HRR (29, 32).   
 
Hypertension  
High blood pressure is the most common risk factor for CVD, affecting about 1 billion 
people world wide (33). Essential hypertension can be defined as a rise in blood pressure 
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(BP) of unknown cause, increasing the risk of cerebral, cardiac and renal events (34). In 
hypertension there is a mismatch between cardiac output, the intravascular volume and 
vasoconstriction resulting in excessive arterial wall stresses that cause endothelial 
damage, atherosclerosis and end organ damage.  
 
The global prevalence of hypertension is increasing and lifestyle factors are strongly 
associated in this development. In western countries about one third of the adult 
population has hypertension and the prevalence of hypertension increases with age (33). 
The life time risk of developing hypertension for an individual with normal BP at the age 
of 55 is set to be 90% during the remaining life time in both sexes (35).  
 
It is estimated that 7 million deaths are attributed to hypertension, thus it stands out to be 
the top global risk factor for cardiovascular mortality. The major hazards of hypertension 
are increased risk of stroke, coronary heart disease and heart failure. The associations 
between BP level and these outcomes are strong, continuous, and independent (33). 
Mortality and morbidity double for every 20mmHg increase in systolic BP above 
115mmHg and for every 10 mmHg increase in diastolic BP above 75 mmHg (36).  
 
Hypertension has a multifactor origin, where more than 250 factors have been identified 
and influence upon the pathophysiological mechanisms of hypertension. The 
pathogenesis is complex and incompletely understood and involves interactions between 
genetic, environmental and demographic factors (37). Some of the major 
pathophysiological causes of hypertension include increased activation of the 
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sympathetic nervous system, and increased renin-angiotensin-aldosterone system 
(RAAS) activity (38). Other mechanisms include vascular and metabolic factors. 
Increased sympathetic nervous system activity increases renin angiotensin II secretion 
and increases noradrenaline release from the sympathetic nerve terminals which 
subsequently stimulates vasoconstriction (39). The kidneys are the main regulators of 
long term blood pressure by adjusting blood volume through urinary sodium and water 
excretion (40), whereas the short term regulation is mainly ensured by hormones, 
mechanical factors and neural reflexes (41). The baroreceptor in the arterial walls of the 
carotid sinuses and the aortic arch are sensitive to mechanical stimuli and provide an 
important feedback mechanism of BP regulation (42).  
 
Classification of hypertension 
Blood pressure has a skewed normal distribution in the population, and there is a 
continuous relation to CVD risk from as low as 110-115 mmHg and 75-70 mmHg at 
systolic and diastolic measurements, respectively (33). Earlier, the diastolic BP was 
emphasized as a predictor of future CVD, and systolic BP was not included in early 
guidelines and hypertension trials (43). However, in a large meta-analysis of 
observational data from 61 studies including almost 1 million persons without 
cardiovascular diseases, both systolic and diastolic BP were independently and similar 
predictive of CVD and all cause mortality (44).  
 
Cut off values for classification of hypertension, may seem artificial, but are set to 
simplify treatment and diagnostic approaches in daily clinical life. In addition, the 
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terminology and different grades of hypertension is widely known and to avoid 
confusion, the classification of hypertension is retained in the latest guidelines (45).  
 
The term hypertension should be considered as flexible and individual, being higher or 
lower based on the subjects total cardiovascular risk.  
 
Table 1. Classification of hypertension, levels in mmHg 
Category Systolic  Diastolic 
Optimal <120  And <80 
Normal 120-129 And/or 80-84 
High Normal 130-139 And/or 85-89 
Grade 1 
hypertension 
140-159 And/or 90-99 
Grade 2 
hypertension 
160-179 And/or 100-109 
Grade 3 
hypertension 
≥180 And/or ≥110 
Isolated systolic 
hypertension 
Ambulatory 
day 
Ambulatory 
night 
≥140 
 
<135 
 
<125 
And 
 
And/or 
 
And/or 
≤90 
 
<85 
 
<80 
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24-hour Ambulatory Blood Pressure (ABP) 
ABP allows a non-invasive measurement of the BP during the entire day and night during 
normal daily activities and nightly sleep.  ABP provides additional information to office 
BP measurements, and is superior to the latter in respect of predicting new CVD events 
both in untreated and treated hypertensive patients (46, 47). It is also less affected by the 
“white coat phenomenon”, thus being more representative for the individual’s true BP.  
Therefore, ABP values correlates better to end organ damage such as left ventricular 
hypertrophy, compared to office BP (45).   
 
In research, the ABP is superior to office BP due to enhanced objectivity and 
reproducibility. Although reproducibility of ABP is better than office blood pressure, 
day-to-day variations are reported in ABP measurements. The differences from one 
measurement to another may be substantial, and the HARVEST study revealed that in 
only one third of the patients there was less than 4/3 mmHg differences for mean ABP 
systolic and diastolic, respectively (48). The day to day variations are probably mainly 
caused by true biological variability, different activity pattern and measurement errors 
due to incorrect cuff size- and placements and arm- movements and position during the 
measurements (48). The reproducibility is incrementally increased by following a simple 
checklist including careful patient instruction (activity pattern, arm position and no arm 
movement during the measurements), sizeable cuff in position, testing the monitor before 
registration and a visual check of the registered 24-hour measurement.     
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Comparative studies of ABP equipment with mercury column sphygmomanometers are 
the gold standard for device validation. Validation of the accuracy with mercury 
sphygmomanometer show accuracy 5 mm Hg between readings (49). Blood pressure 
devices are regularly validated by the British Society of Hypertension’s homepage, 
http://www.bhsoc.org/blood_pressure_list.stm and on 
http://www.dableducational.org/sphygmomanometers.html.  
 
According to the new NICE (National Institute of Health and Clinical Excellence) 
guidelines (50) (51) , ABP is now recommended to verify hypertension diagnosis and to 
monitor treatment in primary care. This is the first time ABP has been included as a first 
step tool in the diagnosis and treatment of hypertension.  
 
Hypertension and physical activity 
There is a graded correlation between hypertension and physical fitness in the population, 
and hypertensive patients have a reduced aerobic capacity compared to their 
normotensive counterparts (52).  
 
Physical activity is recommended in the prevention, treatment and management of 
hypertension, and the anti hypertensive effect of physical activity is generally accepted 
(53). In addition, physical activity has minimal costs and minimal side effects. Studies 
show conflicting results regarding training intensity, duration and frequency (54). In a 
meta analysis by Fagard and Corneliussen (55) it was reported an over all effect of 
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exercise on blood pressure in both hypertensive and normotensive subjects of 3.2 mmHg 
systolic and 2.5 mmHg diastolic BP. Among the hypertensive patients the BP reducing 
effect was more profound, with 6.4 mmHg systolic and 4.3 mmHg diastolic. If ABP is 
applied, the effect has been found to be smaller, and among hypertensive subjects there 
have been noted a reduction by 3.0 mmHg and 3.2 mmHg, systolic and diastolic BP, 
respectively (55).  
 
Endothelial function 
The endothelium forms the interface between the blood and the endovascular and cardiac 
surfaces (56). It covers an area of about 4-7000 square meters and consists of more than 
1013 of cells, weighting approximately 1 kg (57). One important feature of the 
endothelium is the regulation of the vasomotor tone. It is able to respond to physical and 
chemical signals by production of a wide range of factors that regulate vascular tone, 
cellular adhesion, thromboresistance, smooth muscle cell proliferation, and vessel wall 
inflammation (56). In the endothelium several potent vasodilator substances are 
produced, including Prostacyclins, Epoxyeico-satrienoic acids (EETs), H2O2, Bradykinin 
and Nitric oxid (NO). On the other hand, the endothelium is the production site of 
different vasoconstrictors, such as endothelin-1 and is also the site for a small part of the 
conversion of angiotensin I to angiotensin II (renal endothelium).  
 
NO is considered the most important vasodilator and reduced NO bioavailability is often 
considered as synonymous to endothelial dysfunction (58). One of the first signs in the 
pathologic process in atherosclerotic CVD is endothelial dysfunction, and has thus been 
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proposed as the primary mechanism of atherosclerosis. Endothelial dysfunction is often 
seen in hypertension, hypercholesterolemia and diabetes, and is associated with 
incremental risk for CVD. The endothelial production of NO promotes vasodilation, and 
inhibits inflammation, thrombosis and smooth muscle cell proliferation (59). It is also a 
smooth muscle relaxant in the arterial walls and causes enhanced relaxation rate in the 
cardiomyocytes (60).  
 
Bradykinin and Achetylcholin are agonist substrates that lead to increased release of NO. 
Increased endothelial shear stress, due to increased blood flow, also increases NO release, 
with subsequent dilatation of the vessels (normalizing shear stress), a process termed 
“flow-mediated dilatation” (FMD) (61). Aerobic exercise training increases vascular 
shear stress by increasing blood flow, resulting in increased NO production and up 
regulation of the enzyme endothelial nitric oxide synthase (eNOS). Antioxidant enzymes, 
such as superoxide dismutase and glutathione peroxidase. The antioxidant enzymes are 
involved in the scavenging of reactive oxygen species (ROS).  
 
In clinical settings, FMD can be measured in the brachial artery by ultrasound technique 
(62, 63). Placing a sphygmomanometer either above the antecubital fossa or on the 
forearm ceases  blood flow in the artery with the cuff inflated to a pressure well above the 
systolic artery pressure. After five minutes of occlusion the cuff of the 
sphygmomanometer is deflated and reactive hyperemia will occur in the artery. The FMD 
is the difference, measured in %, between the basal diameter and the diameter after 
deflation caused by the reactive hyperemia. This methodology has been debated because 
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the hyperemic response is probably partly confounded by ischemia-induced hypoxia in 
the area being imaged (64). The placement of the cuff is reported to affect the FMD 
measurements and new guidelines suggest placing the cuff distal to the probe, since this 
approach is thought to give a predominantly endothelium-dependent vasodilatation (64). 
However, several studies have demonstrated a prognostic significance of endothelial 
function using a proximal occlusion (65-67). A low FMD response to shear stress is 
considered as an indicator of endothelial dysfunction. There exist no general reference 
values for FMD, as mean FMD varies widely between different studies. This may be due 
to different populations (age, diseases) and measurement techniques (68).  
 
Despite some debate, the general view is that the assessment of FMD represents the 
endothelium derived NO bioavailability in humans (64). If performed appropriately, 
FMD is an easy, relative reliable and gentle measurement of the endothelial function. It 
has shown to be a strong predictor of CVD risk in both healthy populations and in groups 
of patients with known CVD, including hypertension (67, 69-71). However, the method 
remains a population measure, with little diagnostic value in individual diagnoses. 
Reproducibility of FMD has been reported to be in the order of ±11.6%, ±8% and ±7% 
for intra-observer variability, inter-observer variability and repeatability respectively 
(72). 
 
High intensity exercise 
Recent studies have shown that exercise training with a high intensity (>90% of maximal 
heart rate) is more effective to reduce cardiovascular risk factors and improve physical 
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capacity than exercise training performed with a moderate intensity (73-75). This has 
been demonstrated in both healthy subjects and in different patient groups, such as heart 
failure, coronary artery disease, claudicatio intermittens and metabolic syndrome (76-79). 
The mechanisms of increased physical adaptation may be explained by the close relation 
of stroke volume and intensity. Stroke volume increases in concurrence with higher 
intensities, and the largest stroke volume is reached near VO2max. In conclusion, high 
intensity training is probably the most effective training to improve stroke volume. 
Aerobic exercise also improves peripheral factors and high intensity exercise has been 
shown to improve endothelial function and antioxidant status significantly compared to 
training programs performed at lower intensities (76).  
 
Risk of exercise 
Although numerous studies have observed a protective role of regular exercise in the 
prevention of CVD and mortality, there is a definable risk of complications during 
exercise training. Most of the adverse effects are du to musculoskeletal injuries and have 
a non-fatal outcome. Serious cardiovascular events are less common risks, and include 
arrhythmia, sudden cardiac death and myocardial infarction. The risks of exercise are 
more likely to occur in vigorous activity compared to moderate and low intensity 
activities, especially in those who are least fit and least active (80). In younger 
individuals the risk for serious events is almost exclusively related to congenital diseases, 
whilst in older subjects (> 40 years) the risk is most associated to underlying 
atherosclerotic diseases (81). The risk of sudden death is estimated to one death per every 
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15000-18000 subject year (80, 82). In addition, regular physical activity protects against 
sudden cardiac death (2).  
 
Echocardiography and Tissue Doppler Imaging 
Real time two dimensional (2D) examination of the heart combined with Doppler 
technology allows a non-invasive assessment of cardiac anatomy, pathology, function 
and hemodynamics.  
 
The first introduction of ultrasound in cardiology was by Edler and Hertz in Lund in 
Sweden in 1953 (83). The amplitude of the reflected signal at a certain depth can be 
displayed as the brightness of the reflector, called a B-mode (brightness) modality. Depth 
selectivity is achieved by time gating. By plotting repeated B-mode signals along the x-
axis it is possible to record motion, an M-mode modality, which was the first modality to 
record moving reflections from the heart. By sweeping the ultrasound beam in successive 
sectors, two dimensional B-mode images can be created, built up by multiple B-mode 
lines.  
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Figure 1. Parasternal B-mode of the left ventricle, and M-mode image of the mitral 
valve.  
 
The number of lines displayed per second is limited by the ultrasound velocity. The time 
per line is increased if the depth is increased. As an image is built up by a number of lines 
sweeping across a sector, frame rate is also a function of the number of lines, which again 
is determined by the sector width and line density (84, 85). It is possible to increase the 
frame rate, i.e. in order to visualize high velocity moving objects such as the myocardial 
leaflets, but this will reduce the image resolution by reducing the line density.  
2D echocardiography enables the measurement of LV volumes, stroke volume and 
ejection fraction. The most commonly used convention is Simpson’s method (86). The 
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measurement of volumes is susceptible to artifacts due to shadows, poor endocardial 
definition, foreshortening and also lateral resolution due to reduced line density. The 
inter-observer reproducibility of volume measurements by B-mode echocardiography 
without contrast was investigated at our department, showing that the limits of 
agreement, were about -33.3 to 18.1 ml (end diastolic volume (EDV)), -23.5 to 16.5 ml 
(end systolic volume (ESV)) and -16.6 to 14.2% (ejection fraction (EF)) (87). Intra-
observer reproducibility was not reported in this study.  Thorstensen et al reported higher 
reproducibility for cardiac volumes with a coefficient of repeatability of 14 ml and 18 ml 
for EDV, 9 ml and 8.5 ml for ESV and 0.007 % and 0.006 % for EF (inter- and intra-
observer analyses respectively)(88). However, the population in Thorstensen’s study 
differed from the other study by its healthy, young subjects.  
 
Doppler effect 
The frequency of the transmitted ultrasound pulse changes when it is reflected from a 
moving object. The frequency will be higher if the object moves towards the probe and 
lower when the object moves away. The Doppler equation states that the velocity (v) of a 
moving reflector is given by  
    V= 
θcos2 0 ⋅
⋅
⋅ f
f cd  
 
Where ƒ0 is the emitted frequency, ƒd is the Doppler shift, c is the velocity of the 
ultrasound and θ is the angle between the emitted ultrasound and the velocity vector of 
the moving object.  
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Velocity measurements by the Doppler shift are thus sensitive to misalignment between 
the direction of the motion and the direction of the ultrasound. Angle correction cannot 
be used in cardiac measurements, because the directions of tissue and flow are difficult to 
predict and varies during the cardiac cycle. In blood vessels, the direction can be 
predicted from the vessels geometry and since flow direction is constant during the 
cardiac cycle.  
 
Tissue Doppler imaging (TDI)  
Tissue Doppler measurements are based on the same principle as blood flow Doppler 
measurements. Blood has higher velocities and lower amplitude, whereas tissue has 
lower velocities and higher amplitude. The low and high velocities may be filtered to 
measure the desired object.  
 
The myocardial velocities progressively decrease from the base of the ventricles to the 
relatively stationary apex, and the placement of the sample volumes are of importance. 
Measurements in the mitral ring are thus assumed to reflect the general function of the 
entire ventricle (85). In our studies we had relatively healthy subjects with normal 
myocardial function, and we did not do any regional analysis. The Doppler technique is 
angle dependent and it is crucial to be parallel to the movement direction to avoid 
significant underestimation of the real velocity. Furthermore, the myocardial velocities 
assessed by pwTDI from the apical views do not detect radial and circumferential 
myocardial motion, which also contribute to the overall myocardial function.  
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The myocardial velocity profile created by TDI from the apical view is characterized by 
three wave forms; an apically directed systolic myocardial velocity (S’), early diastolic 
(e’) and late (a’) basally directed myocardial velocities.   
 
 
Figure 2. Tissue Doppler imaging of a normal heart. Four chamber view with the sample 
size in the lateral corner. 
 
Two different methods are used to measure tissue velocities; pulse wave (PW) and color 
Doppler method (cTDI) (84). The whole frequency spectrum of the Doppler shift is 
displayed in the PW tissue Doppler method, resulting in a broad band of velocities, while 
in the cTDI method only the mean frequency of the Doppler shift are presented. cTDI 
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velocities corresponding to the middle of the spectrum, and are thus lower than the peak 
PW Doppler measurements. 
 
During the last decade, TDI has been introduced as a more objective and quantitative 
method to assess the myocardial function (89-92). Tissue Doppler recordings are good 
markers of global diastolic and systolic function of the left ventricle (93), and both 
measurements can be obtained at the same time. With TDI it is theoretically possible to 
record tissue velocities anywhere in the myocardium, but for global evaluation of the LV, 
the movement of the atrio-ventricular plane is of most interest. The longitudinal 
velocities of the left ventricle decrease from the base toward the apex (94), since the apex 
virtually does not move. 
 
The peak e’ velocity reflects the early ventricular lengthening of the LV and is a measure 
of the LV relaxation. The e’ velocity is related to the time constant of the isovolumic 
relaxation (tau) and elastic recoil. The load dependency of e’ has been debated, but there 
has been growing support that this index is affected by different loading conditions (95-
97). Decreased preload has shown to reduce e’ in normal hearts, and vice versa, a higher 
preload leads to higher e’ (96, 98). With increasing age there is a gradual decrease in the 
rate of myocardial relaxation and elastic recoil, thus leading to reduced e’ velocity in 
older populations (99). Although e’ has shown to be less dependent by HR (100), a recent 
study suggest that e’ is also affected by HR (101).  
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The S’ velocity reflects the systolic shortening of the ventricle in the longitudinal 
direction, and the peak systolic velocity provides information about the systolic function 
of the ventricle. The S’ velocity recorded in the mitral and tricuspid annulus has shown to 
correlate with the left and right ventricular ejection fractions respectively (102, 103). The 
S’ velocity is reduced during aging (99), and is inversely related to afterload (104).  
 
Recently, our research group has tested the reproducibility of echocardiographic 
measurements in healthy persons (n=10, 7 men 30±6 years) (88). Inter-observer 
reproducibility (different recordings, different analyser) for systolic measurements were 
6, 8, 7 and 4 % mean error for EF, S’ (pwTDI), S’ (cTDI) and mitral annulus excursion 
(MAE) (mm), respectively. For diastolic measurements; 22, 17, 8 % mean error for E/A, 
isovolumic relaxation rate (IVRT) and e’ (pwTDI), respectively. Inter-analyser 
reproducibility (the same recordings, different analyser) for systolic measurements were 
6, 3, 3, and 3 % mean error for EF, S’ (pwTDI), S’ (cTDI) and MAE (mm), respectively. 
For diastolic measurements; 10, 7 and 3 % mean error for E/A, IVRT and e’ (pwTDI), 
respectively. Intra-analyser (same recordings, same analyser) for systolic measurements 
were 5, 2, 2 and 3 % mean error for EF, S’ (pwTDI), S’ (cTDI) and MAE (mm), 
respectively. For diastolic measurements; 5, 3 and 2 % mean error for E/A, IVRT and e’ 
(pwTDI), respectively. Intra-analyser analyses showed that the reproducibility is fairly 
good. We examined relatively healthy persons and the results from Thorstensen et al. 
may be comparable to our studies.   
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Myocardial function and aerobic capacity 
Acute hemodynamic changes occur from resting state to exercise, with increased HR and 
SV along with the increase in intensity and VO2max. The relation between the increase in 
SV and VO2max has been debated (105). The traditional view is that SV increases in 
untrained and less fit subjects by 20-30 % with progressively increasing workload, and 
then plateaus until exhaustion. However, some studies in well-trained subjects have 
shown that SV continue to increase linearly nearly up to VO2max (106, 107). This may, 
however, be one of the mechanisms of training adaption in well-trained subjects. 
 
Stroke volume may be influenced by ventricular volume, preload, myocardial 
contractility and afterload. During exercise there is increased venous return, caused by 
the peripheral muscle pump. This does not necessarily increase preload, as increased 
ventricular suction during exercise may be the sole mechanism for increased filling (108). 
This may be a result of both increased relaxation rate due to increased sympathetic tone, 
and increased elastic recoil due to increased systolic contraction (109). Increased 
myocardial contractility is caused by a shift in the activity of the autonomic nervous 
system from parasympathetic to sympathetic dominance, also causing increased 
circulating catecholamines. Peripheral resistance is reduced by a vasodilatation in the 
working muscles leading to a reduced afterload. Increased CO raises systolic BP, whereas 
the diastolic BP increases less, or even decreases due to the reduced peripheral resistance.  
 
At prolonged exercise at moderate intensity (50-70% of VO2max) HR progressively 
increases after 10 minutes, while SV and mean arterial and pulmonary pressures decrease 
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progressively. Cardiac output is held relatively constant (105), a situation referred to as 
cardiac drift.  
 
If exercise is prolonged >45 minutes, VO2 tend to decrease. The reasons are not fully 
elucidated, but according to Fick’s equation the stroke volume or the a-vO2 difference are 
involved. Several studies indicate that the latter is not the case, but rather a reduction in 
SV (110). This may be caused by reduction in preload due to greater cutaneous 
vasodilatation, dehydration and reduced plasma volume. The increased HR may in 
addition contribute to a shorter filling time and a reduced end diastolic volume (110). 
These factors may have implications in the use of HR as a measure of intensity.  
  
Long term myocardial adaptations to exercise 
Athletes participating in endurance exercise are primary exposed to a volume load on the 
myocardium, and to a lesser extend a pressure load as seen in isometric exercise such as 
weightlifting (111). The results are increased LV chamber size with a proportional 
increase in wall thickness, which is described as eccentric hypertrophy. Endurance 
trained athletes have a high CO and thus a high venous return which also cause an 
increase of the atria and the right ventricular chamber. Even though the athlete’s heart 
increases in size, control mechanisms restrain “over growing”, and keep the heart 
approximately in the same size. In humans, cardiac output can increase from resting state 
to 5, 6, or 8 times during exercise in athletes but the stroke volume never more than 
doubles. The end-diastolic volume increases only by about 50% and the end-systolic 
volume decreases by the same amount; whereas heart rate may increases from resting HR 
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to HRmax by two and a half times in the untrained to 5 times in the physically fit athlete 
(21). This, however, is due to a lower resting HR in athletes, as the maximal HR tends to 
be slightly lower in trained than in sedentary subjects. The main adaption in athletes is 
increased LV end diastolic volume, with normal or slightly increased wall thickness, 
hence increased LV mass (eccentric hypertrophy). The increased LV volume results in a 
higher LV stroke volume reserve. The wall thickness remains at, or slightly above upper 
normal limit (112). Functional parameters by tissue Doppler shows normal systolic and 
diastolic function, as opposed to pathological hypertrophy, although the discernment may 
be difficult in some cases (113).  
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Objectives and hypothesis 
The primary aims of the studies were to: 
 
Paper 1. 
Compare the effect of high intensity aerobic interval training to moderate continuous 
training on blood pressure and myocardial function in hypertensive patients.  
 
Hypothesis: Moderate continuous training reduces systolic blood pressure in 
hypertensive patients, but aerobic interval training reduces systolic blood pressure 
significantly more.  
 
Paper 2. 
Evaluate and compare the effect of aerobic interval training on myocardial function in a 
cohort of sedentary seniors, and to compare the results with a young healthy population 
and well trained seniors.  
 
Hypothesis: Age related reduction in diastolic function is partially related to ageing, 
partially to inactivity. Thus, diastolic function is better in well trained seniors, but can be 
improved by exercise in healthy sedentary seniors. 
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Paper 3. 
Compare the effect of high or low frequency of aerobic interval training on aerobic 
capacity and myocardial function in young healthy individuals.  
 
Hypothesis: There is similar effect of high or low frequency training on VO2max  (and 
myocardial function) as long as total numbers of training sessions are equal.  
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Materials and Methods 
Subjects 
Paper 1  
The first study was a randomized trial consisting of 88 patients (52.0±7.8 years, 39 
women) with mild to moderate essential hypertension. The patients were recruited locally 
by an advertisement in the regional newspaper, Adresseavisen.  
 
Inclusion criteria were essential hypertension grade 1-2 (mild to moderate) defined as 
systolic blood pressure (SBP) 140-179 mmHg and/or diastolic blood pressure (DBP) 90-
109 mmHg (53), age <65 years.  Patients with secondary hypertension, indications of end 
organ affection (left ventricular hypertrophy, retinal changes, micro albuminuria) or three 
or more risk factors for CVD (53), as well as patients using more than one 
antihypertensive drug were excluded. Before inclusion, 39 patients used an 
antihypertensive drug. This was terminated, and they were observed for a wash-out 
period of 1 month before inclusion to avoid influence of the medical treatment. The 
patients were randomized to either aerobic interval training (AIT, n=31), moderate 
continuous training (MIT, n= 28) or to a control group (C, n=29). To fulfill a study 
criterion of 90 % compliance to the training program we registered 6 drop outs in the AIT 
group, 5 in the MIT group and 4 patients in the C group. In the AIT group three patients 
did not fulfill the training program due to a lack of motivation and three patients because 
of pain. In the MIT group three patients lost their motivation and did not complete the 
training program, whilst one patient had to quit due to a myocardial non-ST-elevation 
infarction he sustained at home, and the last patient had to quit because her blood 
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pressure rose during the study period and exceeded the inclusion criteria. In the C group 
three patients lost their motivation and one started intense training on his own initiative 
and thus had to be excluded from the analysis.  
 
The total patient population for analysis was done with 25 patients in AIT, 23 in MIT and 
25 in C. 
 
Paper 2 
In the second paper,19 healthy sedentary seniors (73 3 years, 8 women) were recruited 
through the regional newspaper, Adresseavisen. The participants performed AIT for 
twelve weeks. Inclusion criteria were age > 70 years and not exercising more than twice 
per week for the last two years. Persons with any chronic illness or chronic use of any 
medication, regular smoking, or any metabolic or cardiovascular abnormality were 
excluded. Three patients dropped out, one because of a leg muscle injury and two for 
reasons not related to the study. The drop outs were lost to follow up.  
 
The results of the male seniors were compared to 11 senior Master Athletes (74 2 years, 
all males) who were recruited from the top ten results of a national ski content 
(Birkebeinerrennet, Rena-Lillehammer, distance 54 km)(from two different subsections, 
70-75 years old and from 75 years and older). All of them had exercised regularly (>5 
times/week) the last 25 years and the majority of the participants were still competing at 
the top national or international level for their age group. They were all still physical 
active, maintaining an exercise frequency of at least 5 times per week.  
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The results were also compared to 10 healthy male sedentary students (23±2 years) that 
were recruited from the Norwegian University of Science and Technology, who also 
participated in study 3.  
 
Paper 3 
In the third study, 21 healthy sedentary students (23.0 ± 2.1 years, 10 females) were 
randomized from Norwegian University of Science and Technology to high intensity 
interval training, either at a high frequency program of 8 sessions per week for three 
weeks (n=11 female/male=6/5), or to a moderate frequency program consisting of 3 
sessions per week (n=10, f/m=4/6) for eight weeks. Thus both groups accomplished an 
equal number of AIT training sessions. There were no drop outs in either group.  
 
Inclusion criteria were healthy, non-smoking students that were not exercising more than 
twice weekly the last year and with a VO2max ≤ 50 ml/kg/min for women and 60 
ml/kg/min for men (measured at our laboratory at baseline).  
 
Ambulatory blood pressure measurement 
Ambulatory blood pressure monitoring in study 1 was performed with an oscillometric 
TM-2430 Recorder (A&D Co LTD, Tokyo, Japan. This device is validated for clinical 
and research use, ranked with a top rating, A/A, classified by the British Society of 
Hypertension (114, 115). The inter-observer reproducibility has been reported to be 
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0.6±2.6 mmHg for systolic and 0.2±2.2 mmHg for diastolic BP measurements, 
respectively (114).    
 
The cuff was fixed to the non-dominant arm. BP measurements were done every 15 
minutes during daytime, defined as 7.00 am to 10.00 pm, and every 30 minutes during 
night time, defined as 10.00 pm to 7.00 am. The recordings were accepted if at least 75% 
of the recordings were obtained. Values were deleted if SBP >240 mmHg and 
<80mmHg, and/or DBP >140 and <40mmHg, and/or if pulse pressure >110mmHg or 
<20 mmHg. The devices were programmed to do another measurement if there was a 
change between consecutive readings of SBP >50mmHg DBP >40mmHg and pulse 
pressure>50 mmHg. If the ABP failed to measure the BP, another ABP was performed. 
The values used in the analysis were average values, and variation displayed as SD.  
 
Exercise testing 
In all three papers we measured VO2max by the same test protocol. The test situation and 
the exercise sessions were performed fairly similar, with the subjects walking or running 
uphill on a treadmill (Figure 3). We believed that this would be an advantage as the 
situation would be known for the study participants, and it would further reflect a true 
VO2max rather than local fatigue related to the use of other less used musculature, as has 
been reported as a problem when bicycle testing has been used (21). Jogging or running 
uphill involves large muscle groups necessary to reach VO2max. This method has been 
found to achieve about 5 % higher VO2max compared to stationary bike cycle testing in 
untrained individuals (21).  
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Maximal oxygen uptake was measured by Cortex Metamax II portable metabolic test 
system (Cortex Biophysics GmbH, Leipzig, Germany). This device has been validated 
against the Douglas Bag method, which is thought of as the gold standard (116, 117) 
(mean differences of measured VO2 was 0.03, 0.02, and 0.04 L·min-1 for 100, 200, and 
250 Watt, respectively). Reproducibility is accurate if the system is calibrated and tested 
regularly, intra-class reliability has been found to be 0.984 (± 0.2ml L·min-1) for VO2 
measurements (116).   
 
We used an individualized graded ramp protocol. After a 10 minutes warm-up, a 
facemask was placed on the subject’s face for ventilatory analysis.  Incline was constant 
at 10% and band speed increased every minute until VO2 leveled off (< 2 ml/kg/min 
increase) despite further increased work load, and a respiratory exchange ratio >1.10 was 
reached. The test was completed within 8-12 minutes.  
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Figure 3. Exercise testing in our laboratory.  
 
Maximal heart rate, heart rate recovery and resting heart rate 
HRmax was measured during the VO2max test procedure. The maximal heart rate obtained 
during the test was always reached during the final minute of the test. True HRmax is 
reached after several repeated intervals of maximum effort, and after several minutes at 
the last interval. The heart rate obtained at the end of the test is thus usually lower than  
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HRmax. To obtain an estimate of HRmax, we added 5 beats per minute to the HR at peak 
exercise.  
 
In paper one, we measured heart rate recovery, defined as the reduction  in heart rate 
from peak exercise to one and two minutes after terminating the test (118). The subjects 
in paper one were patients with essential hypertension and it was assumed that the 
exercise training would involve a reduction in the sympathetic nervous tone. In papers 
two and three the subjects were healthy, and HRR was not measured, as it would 
probably not give additional information more than the progression of training status.  
 
Resting heart rate was measured in all three studies during the resting echocardiography 
examination. The measurements were calculated by the mean of three heart beats. In 
general, the subjects had rested about 10 minutes at that time.  
 
Training intervention 
Training at high intensity, >90 % of HRmax has significantly shown  increased VO2max and 
reduced CVD risk factors, compared to training at lower intensities in both healthy 
people and in different patient groups (76, 79, 117). The high intensity is only possible to 
maintain in short periods, as it is above the anaerobic threshold. In our study we chose 
four minutes intervals (>90% of HRmax), performed four times with three minutes active 
breaks in between (70% of HRmax) to eliminate lactic acid. The training sessions always 
started with a ten minutes warm-up and rounded off with a three minutes cool down. 
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Total time was set to 38 minutes. Intensity (speed or incline) was increased during the 
intervention period to keep HR at the same level, in order to maintain relative intensity as 
fitness increased.  This has been proven to be an effective method (Figure 4), clearly 
demonstrated by our department in several recent studies (76, 77, 79, 117, 119).  
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Figure 4. Aerobic interval training model.  
 
In paper one, we compared if the AIT was more effective to lower blood pressure than 
isocaloric continuously training at a moderate intensity (MIT) at ~ 70% of HRmax. The 
MIT was performed as walking/running for 47 minutes, being isocaloric to AIT (117).  In 
general, the moderate intensity training applied in our study is referred to as high 
intensity training in the existing literature and has shown to have a documented 
antihypertensive effect (52).  Both training forms were performed on uphill treadmill 
walking or running. To ensure that the required intensity was maintained, the participants 
monitored their HR with Polar HR monitors (Polar, Kempele) and were controlled, 
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backed up and supervised by a personal trainer. The training sessions were performed 
three times a week for twelve weeks.  
 
In paper two and three no other training method than AIT was applied. In paper two we 
were interested to study if seniors aged >70 years, could improve their VO2max to the 
same relative extent as seen in young populations and if it could to some degree reverse 
the age related impairments of the left ventricular function.  AIT was performed three 
times a week for twelve weeks.  
 
The rate of adaptations has been questioned, and we aimed to study if the effect of AIT 
could be achieved in a shorter time by increasing training session frequency. In paper 
three, the healthy young students completed 24 sessions of AIT either in three weeks or 
in eight weeks.  
 
Endothelial function 
In paper one and three, we measured endothelial function as FMD of the brachial artery, 
using high resolution vascular ultrasound (12MHz echo Doppler probe, Vivid 7 system, 
GE Vingmed Ultrasound, Horten, Norway). The procedure followed in paper one is 
described by Coretti et al (62), and the cuff for occlusion of the artery was placed 
proximal to the ultrasound probe. In paper three we placed the cuff distal to the probe to 
exclude any influence of ischemic processes (64). No difference where observed in paper 
one after NO was administrated sublingually, indicating that the response reflected the 
bioavailability of NO in both methods. 
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The lumen diameter of the artery was measured at three consecutive R-waves times and 
an average was used as baseline values and after one minute after cuff release. The 
percent change in diameter was used as FMD. All measurements were done in a quiet 
room after >8 hours fasting from food, caffeine, tobacco and alcohol. The participants 
were told to avoid strenuous activity 24 hours before the measurements.  
 
Echocardiography 
In paper one only 51 patients obtained an echocardiogram due to capacity problems. In 
addition, recordings were performed at rest only. In paper two and three all patients were 
examined by echocardiography at rest and during exercise. In paper three, 
echocardiography was done at baseline, after the training period and after the detraining 
period. In all three papers we used a Vivid 7 scanner (GE Vingmed Ultrasound, Horten, 
Norway) with a phased array transducer (3MS probe).  
 
The resting echocardiography examinations were done with the subjects in the left lateral 
decubitus position. Three consecutive cardiac cycles from the three standard apical views 
(4-chamber, 2 chamber and long axis) as well as short axis (basal, mid-papillary and 
apical) were recorded by conventional two-dimensional (2D) harmonic grey scale mode 
and in colour tissue Doppler mode. The loop with the best quality was chosen for the 
analysis. B-mode recordings were done with an average of 53-54 frames per second and 
tissue Doppler with 150-154 frames per second. M-mode recordings were done in 
parasternal short axis view. Pulsed Doppler flow recordings of the mitral inflow were 
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obtained with the sample volume between the tips of the mitral leaflets. Measurements 
included early diastolic filling (E) and late diastolic filling (A). Isovolumic relaxation 
time (IVRT) was measured with the sample volume between the aortic and the mitral 
annulus, imaging the aortic valve closure click as well as the start of the mitral inflow. 
Stroke volume (SV) and cardiac output (CO) was calculated by Doppler flow 
measurement in the left ventricular outflow tract (LVOT) together with LVOT diameter 
and HR. LV volumes and ejection fraction (EF) were calculated from apical recordings 
by modified biplane Simpson’s method (86). 
 
PwTDI velocities were recorded with the sample volumes placed in the mitral ring in the 
septal and lateral position of the four-chamber plane, and the anterior and inferior 
positions in the two-chamber plane. In all three papers we used the average velocity of 
the four positions as global measures.  
 
Exercise echocardiography was obtained in paper two and three (additional information 
regarding paper 3; exercise data not sent for publication). Recordings were done sitting 
upright on a stationary bike at rest and during exercise at ~70% of HRmax (calculated from 
the VO2max test). During upright stress testing, it is difficult to make accurate 
measurements due to the movements of the subject. Therefore we used cTDI to record 
myocardial tissue velocities, and analyses were done in post processing, measuring 
values of the mitral ring as described for resting echocardiography. Doppler flow 
recordings were obtained from four-chamber view and cTDI recordings was obtained in 
four-chamber and two-chamber view. The average value of four points was used in the 
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analysis. These values are lower than pulsed tissue Doppler velocities since cTDI 
velocities represent the mean instantaneous velocities (85). Due to a fusion of early 
diastolic tissue velocity and late diastolic tissue velocity during exercise, only the highest 
value was used as a measurement of e’. Blood pressure was measured conventionally at 
rest, sitting in a chair, according to standard procedures (53) and at submaximal exercise, 
sitting on bike, to assess hemodynamic changes.  
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Figure 5. Patient with hypertension and diastolic dysfunction. The image at top shows 
reduced E/A ratio, prolonged IVRT and prolonged deceleration time. The image below 
shows reduced tissue Doppler velocity, e’ (85).  
 
Blood samples 
In paper one and three the following blood samples were analyses were done at St Olavs 
University Hospital with standard procedures: Serum triglycerides, glucose, high-density 
lipoprotein (hdl), low-density lipoprotein, total cholesterol, hemoglobine, sodium, 
potassium and creatinine. Blood were obtained after at least 8 hours of fasting from food, 
caffeine, nicotine and alcohol.  
 
Statistics 
Data are presented as mean (SD). All statistical analyses were done with SPSS (SPSS, 
Inc, Chicago).  
 
In all three papers we applied independent or paired t-test to discover within group 
differences. Analysis of variance was used in paper two to discover differences between 
the three male groups. One way analysis of covariance (ANCOVA) which is the 
preferred approach for analyzing randomized trials with baseline and follow up 
measurements (120) was used to discover between group differences in paper one and 
three. Covariance was used to avoid influence of different baseline values among the 
subjects, but in both study one and three this was not strictly necessary with the primary 
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outcome since baseline values were not significantly different. Post-hoc adjustment with 
Bonferroni correction and a two sided p<0.05 was regarded as marker of statistical 
significance in all three papers.  
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Summary of results 
Paper 1. 
The principal outcome was ABP. AIT reduced systolic ABP by 12 mmHg (p<0.001) and 
diastolic ABP by 8.5 mmHg (p<0.001), whilst MIT reduced systolic ABP by 4.5 mmHg 
(p<0.01) and diastolic ABP by 3.5mmHg (p<0.05) (Figure 6). There was a significant 
difference comparing the effect on the systolic ABP between the two training groups 
(p<0.05). No changes were seen in the control group. In the control group there was a 
non significant trend for BP reduction during observation by 2 mmHG both for systolic 
and diastolic pressure. Although not significant, this may be the order of magnitude of 
regression towards the mean, as the selection criterion was the same as the primary 
outcome.  
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Figure 6. 24-hour ambulatory blood pressure. 
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Graphs display average reduction in ABP for  AIT: Aerobic interval training group, 
MIT: Moderate continuous training group, C: Control group.   
* indicates: p-value<0.05 compared to control group. ** indicates p-value<0.001 
compared to control group. # indicates p-value<0.05 AIT group compared to MIT group. 
 
Secondary outcomes were VO2max, HRR after one and two minutes, mean HR-24 hours, 
endothelial function, myocardial function, total peripheral resistance, quality of life and 
Hdl cholesterol. AIT improved VO2max by 15 % (p<0.001) and MIT 5% (p<0.01) (group 
difference p=0.001). Only the AIT group achieved a significant improvement in heart rate 
recovery with 7 beats/min (p=0.01) and 8 beats/min (p=0.04) recorded one and two 
minute post-exercise, respectively. Only the AIT group achieved a reduction in HRmean, 
with 3.8 beats/min/24-hours (p<0.01). Endothelial function improved only after AIT 
(p<0.01 within group, between group differences, p=0.02). Endothelial-independent 
dilatation did not change. Only the AIT group improved left ventricular ejection fraction 
(6.5 %points (11.2% relative increase), p<0.001), stroke volume (11%, p=0.02), systolic 
flow velocity (9.3%, p=0.03), end-diastolic volume (11%, p=0.01), and early diastolic 
mitral annulus tissue velocity, E’ (14%, p<0.001). Systolic mitral annulus tissue velocity, 
S’ increased by 15% (p<0.001) after AIT and 8% (p=0.04) after MIT. No significant 
changes were seen on conventional diastolic markers (E, A, DT). The isovolumic 
relaxation time decreased significantly in the AIT group only, with 16% (p<0.01). TPR 
decreased by 18.4% (p=0.03) in AIT and 12.8% (p=0.06) in MIT. Hdl-cholesterol 
increased in AIT group with 5.3% (p=0.04), all other general clinical parameters 
remained unchanged in all groups. AIT improved QL in three sub domains: general 
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health (p=0.02), social function (p=0.04) and physical function (p=0.02). MIT showed 
improvement in general health (p=0.03). No changes were seen in the control group.  
 
Table 2. Physiological measurements 
 
 
 AIT (n=25) MIT (n=23) C (n=25) 
Baseline Follow up p-value Baseline Follow up 
p-
value Baseline Follow up 
p-
value 
VO2max, 
ml/kg/min 
36.3±8.8 41.5±10.6 <0.01* 34.0±7.0 35.8±6.9 <0.01 34.7±7.8 35.7±7.6 0.06 
FMD,  
% dilatation 
6.49±3.71 10.66±5.00 <0.01* 6.50±5.01 7.11±5.10 0.70 8.01±4.62 8.91±5.20 0.39 
HR red 1 
min, b/min 149.7±13.9 143.1±14.9 0.01* 149.4±11.0 151.4±9.8 0.35 149.5±16.0 149.3±14.5 0.90 
HR red 2 
min, b/min 128.9±16.2 120.9±14.9 0.04 129.0±10.5 126.6±12.1 0.86 123.6±16.7 127.5±12.9 0.24 
Peak HR  
b/min 
184.0±9.7 180.0±9.9 0.02 181.5±7.8 182.5±9.2 0.65 180.0±12.1 182.5±11.9 0.06 
 
 
Table published in European Journal of Cardiovascular Prevention and Rehabilitation (121). 
Data are mean (SD). VO2max: maximal oxygen uptake. FMD: flow mediated dilatation. HR red 1 
min and HR red 2 min: heart rate recovery/reduction after 1 and 2 minutes after test, 
respectively. Peak HR: peak heart rate. 
 * indicates p-value ≤0.05 between AIT and MIT. Comparison between training groups and control 
group is not displayed.  
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Table 3. Echocardiographic measurements 
 
 AIT MIT C 
 Baseline Follow-up P-value 
within 
group 
Baseline Follow-up P-
value 
within 
group 
Baseline Follow-up P-
value 
within 
group 
EF, % 58.0±4.5 64.5±6.7 <0.001* 59.5±7.6 61.0±8.7 0.25 59.0±9.3 58.0±7.8 0.50
EDV, ml 110±31 122±31 0.01 116±22 117±24 0.79 120±21 123±25 0.55
SV, ml 72.1±11.7 80.1±14.8 0.02 68.3±15.4 71.1±18.2 0.48 75.3±16.7 72.2±13.1 0.29
CO, L/min 4.6±0.7 5.2±0.9 0.05 4.5±1.1 5.0±1.3 0.09 5.3±1.27 5.0±1.04 0.25
HR at rest,  
b/min 
65.0± 6.0 66.5± 9.0 0.50 65.5±11.0 72.0±12.0 0.11 71.0±10.0 69±8.0 0.45
IVRT, m/s 96.5±11.5 81.0±13.6 0.02 91.0±29.9 89.0±23.3 0.59 102±13.7 97.0±10.1 0.12
E, m/s 0.74±0.15 0.77±0.16 0.40 0.67±0.14 0.66±0.15 0.74 0.70±0.21 0.69±0.18 0.69
A, m/s 0.62±0.09 0.62±0.09 0.91 0.65±0.11 0.68±0.17 0.49 0.68±0.22 0.64±0.21 0.22
S' cm/s 6.89±0.90 7.90±1.30 <0.001 7.40±1.20 7.99±1.36 0.03 7.52±1.50 7.07±2.13 0.53
E', cm/s 8.06±1.60 9.26±1.80 <0.001* 8.93±2.11 8.62±2.27 0.42 8.70±1.81 8.27±1.90 0.24
TPR,  
dynes*sek*cm-
1 
2050±295 1669±361 0.03 2120±541 1846±599 0.06 1863±580 1891±416 0.80
 
Table published in European Journal of Cardiovascular Prevention and Rehabilitation (121). 
Data are mean (SD). EF: ejection fraction. EDV: end diastolic volume. SV: stroke volume. CO: 
cardiac output. HR: heart rate differs from table 1 and 2, as this is measured during the 
echocardiographic examination,. Mainly in order to evaluate other echo measurements.. IVRT: 
isovolumic relaxation time. S: systolic peak flow velocity in left ventricular outlet tract.  E: peak 
mitral inflow velocity during early filling. A: peak mitral inflow during atrial systole. E’: peak 
annulus tissue velocity during early filling. TPR: total peripheral resistance. 
*indicates p-value <0.05 between AIT and MIT. Comparison between training groups and control 
is not displayed.  
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Paper 2.  
Study two consists of three different parts. Firstly, a cross sectional study were performed 
where a group of healthy, sedentary seniors, were compared to well trained seniors (old 
Master athletes) and to a group of young, sedentary students. Among the Master athletes, 
we were only able to recruit men and therefore the comparison between the three groups 
was done with males only to avoid gender effects. This comparison shows that old males 
regardless of fitness status have a reduced diastolic function, as measured by e’, 
compared to young males. However, the old Master Athletes had a trend to 23% higher e’ 
than the sedate seniors (p=0.08).  
 
Secondly, a prospective training intervention was performed in the sedentary seniors, 
including both men and women, to assess the training effects of short term training in 
sedentary seniors. The diastolic function, measured by e’, improved in the sedate seniors 
(p<0.05) after the intervention (both genders). VO2max  increased by 15% (p<0.01). After 
the intervention, the male portion of the senior training group was compared to the master 
athletes to assess the training effects of short term versus life long training among healthy 
seniors. The e’ increased by 11% (p<0.05) among the sedate seniors after the intervention 
and equalized the difference compared to the old Master Athletes (p=0.20). Secondary 
outcomes such as VO2max, EDV and e’ measured during exercise increased by 11.5 % 
(p<0.01), 22% (p<0.01) and 7.5% (p<0.01) respectively, but was still different from the 
Master Athletes.  
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Table 4. The effect of intervention, comparison seniors versus Master athletes. 
Males only. 
 
 
 Seniors 
(N=10) 
  Master 
Athletes 
(N=11) 
Comparison 
Seniors-
versus 
Master 
Athletes 
 
 Pre Post P-value 
within 
group 
Baseline P-value 
pre-values 
P-value 
post-
values 
       
VO2max, 
ml/min/kg 
35.0±5.0 39.0±7.2 <0.01 49.5±4.5 <0.01 0.01 
EDV, ml 102±13 124±15 <0.01 142±21 <0.01 0.05 
SV, ml 79±13 87±11 <0.01 102±26 0.03 0.20 
E/A 0.92±0.27 1.35±0.36 0.06 1.33±0.70 0.10 0.92 
e’, cm/s 6.9±1.5 7.5±1.3 0.10 9.0±2.1 0.03 0.20 
S’,cm/s 7.3±0.8 7.6±1.1 0.45 8.2±1.60 0.10 0.30 
HR 
submax 
126±7 128±7 0.94 118±10 0.06 0.04 
SVsubmax, 
ml 
88±16 106±20 <0.01 132±26 <0.01 0.02  
COsubmax, 
l 
10.7±2.2 13.4±2.7 <0.01 14.5±1.9 <0.01 0.40 
e’submax 
cm/s 
12.1±2.1 13.0±2.2 0.12 14.4±1.4 0.03 0.05 
S’submax 
cm/s 
8.4±1.5 10.8±1.6 <0.01 11.9±1.2 <0.01 0.20 
 
 Data are mean (SD). VO2max: Maximal oxygen uptake, EDV: end diastolic volume, SV: stroke 
volume, E/A: E/A ratio Early diastolic mitral inflow/late diastolic mitral inflow, e: early diastolic 
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tissue velocity, S’: systolic tissue Doppler velocity, e’submax: early diastolic tissue velocity during 
stress test, S’submax: systolic tissue velocity during stress test  
 
Paper 3. 
The primary outcome in paper three was VO2max. Both groups increased their VO2max, but 
VO2max peaked varied at different time points indicating different adaptation rate. 
Independent of time point measurements, the moderate frequency (MF) group increased 
peak VO2max by 12.1% (p<0.01)(day four after training cessation) and the high frequency 
(HF) group increased peak VO2max 7.1 % (p<0.01, between group differences, p= 0.319) 
(day 12 after the training cessation). Initially, there was a non-significant decline in the 
HF group after the training period. However, there was no difference in the magnitude of 
VO2max improvements when comparing the two groups during the study period. 
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Figure 7. Time points of VO2max measurements. 
Mean values and standard error of the mean of VO2max for the two groups during the training and 
the detraining period are shown. Vertical dotted line states the last day of training. 
Echocardiography was obtained at baseline, between test 3 and 4 and at week 17.  
*Indicates significant differences from baseline within groups. 
 
The secondary outcomes were myocardial systolic and diastolic function, lung diffusion 
capacity, endothelial function and blood samples. After the training period we observed 
an increased SV and EF measured at rest in the MF group only (p<0.05). EF measured at 
rest decreased in the HF group (p<0.01). EDV and SV increased after the detraining 
period in the HF group. All cardiac measurements were normalized to baseline values in 
the MF group after the detraining period. The lung diffusion capacity was increased in 
the MF group after the training period, whilst a reduction was observed in the HF group. 
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Lung diffusion capacity was normalized to baseline values in both groups during the 
detraining. There were no changes in either groups regarding endothelial function or 
among the blood samples analyzed. We concluded that the two training programs yielded 
different cardiopulmonary adaptations; a moderate frequency program caused a 
progressive cardiopulmonary adaptation during the training program and conversely a 
progressive loss of adaptation in the detraining period. On the other hand, a high 
frequency program induced a transient fatigue that initially depressed the 
cardiopulmonary function, but resulted in a super compensation during the detraining 
period and had a longer lasting effect.  
 
Additional information not included in the paper: Exercise echocardiography supports 
our cardiac findings at rest showing that S’ measured during exercise decreased in the HF 
group after the training period. This was compensated after the detraining and tended to 
increase from baseline measurement.  
 
Discussion 
An effective treatment strategy of essential hypertension  
Study one demonstrates that the antihypertensive effect of endurance training in essential 
hypertension may be intensity dependent (Figure 6). The AIT group reduced average and 
night time systolic ABP more than the MIT group, and only the AIT group reduced the 
average HR during 24 hour.   
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The blood pressure reducing effect of dynamic aerobic training is generally accepted (53) 
and according to the American College of Sports Medicine, categorized as evidence A 
(52). Numerous studies have shown that endurance training has an antihypertensive effect 
(52, 55, 122). The correlation between exercise intensity and BP reducing effect has been 
debated and there are conflicting results in the literature (52, 55, 123). Most reviews have 
concluded that low intensity training is as effective in lowering blood pressure as training 
at higher intensities (45, 55). However, the majority of these studies have investigated the 
effect of exercise intensity training below 85% of maximal heart rate (HRmax), and few 
studies have compared different intensities directly (54). In studies where two or more 
training regimens are compared there have often been different intensity, duration and 
exercise mode (54). Fagard and Cornelissen performed a well designed cross-over study 
to investigate the role of intensity on the BP reducing effect of endurance training (124). 
Two groups were randomized to either a training program with 33% of heart rate reserve 
or 66% of heart rate reserve (corresponding to 59% and 79% of HRmax respectively). 
They could not find any relation between intensity and systolic BP, but the higher 
intensity group reduced diastolic BP more than the lower intensity group. However, in 
their study, only five of the participants had hypertension while the others had normal 
BP. Further, they observed the largest effect among those with the highest baseline BP. 
Our patients were all classified as moderate hypertensive patients with mean systolic 
ABP by 152 mmHg. In addition, both training groups in Cornelissen and Fagard’s study 
performed continuous training where the applied intensities were fairly similar to our 
continuous moderate group. Their results correspond to the findings observed in the MIT 
group in paper one. To our knowledge there has not been performed studies with 
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hypertensive subjects prescribed to exercise at an intensity >85% of HRmax. As the 
relation between VO2max and the magnitude of BP reduction is well established (54), the 
most effective training program to increase VO2max would thus expect to result in largest 
BP reduction. In a short term view, this would favour training with a high intensity (117). 
Our results seem to substantiate this.  
 
In paper two, AIT reduced office systolic and diastolic BP among healthy seniors. Aging 
causes changes in the vasculature that in part may be comparable to hypertension, with 
increased stiffness, intimal wall thickening and reduced compliance. As the walls of the 
arteries stiffen, central systolic arterial pressure increases, whilst the diastolic arterial 
pressure decreases. A widened pulse pressure is an independent risk factor for future 
CVD events (125). Isolated systolic hypertension is the most common form of 
hypertension after the age of 50 (126). Among young persons the BP is mainly 
determined by the peripheral vascular resistance (TPR), but in older subjects it is 
determined to a greater extend by increased stiffness in the central arteries (127). Also, it 
has been proposed that increased vascular stiffness precedes the development of 
hypertension (128). This suggests that hypertension may primarily be a disease of the 
arterial wall, causing structural changes in the vasculature, and those compensatory 
mechanisms to normalize BP fails during ageing. As an example is the observation of the 
marked reduction in endothelial function, measured by FMD, at the 6.th decade (129). 
This means that structural changes are normalized by functional compensatory 
mechanisms, but when these functional mechanisms fail, such as reduced production of 
eNos, hypertension will develop. 
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Acute effects of exercise on blood pressure 
During the first minutes of endurance training,  elevated oxygen demand creates an initial  
increase in  CO due to a reduction in parasympathetic activity. This is gradually followed 
and replaced by an increased sympathetic activity (130). Increased CO and 
vasoconstriction of the non-exercising vascular beds result in elevated systolic BP, but 
the working muscles increase local blood flow and the net result is a reduction in TPR. 
Diastolic BP is reduced or slightly elevated (caused by the occlusion of blood flow by the 
forceful contractions of the exercising muscle). After exercise has been terminated, there 
has been observed a reduction of plasma catecholamines, CO, plasma volume and TPR 
(52, 131). The phenomena of the acute effect of BP reduction after a single bout of 
exercise was discovered in 1897 by Hill (132) and is referred to as post exercise 
hypotension (PEH). The effect of PEH has been observed to last from 2 to 22 hours (52). 
The transient effect is thought to accumulate and may be responsible for some or even 
most of the chronic BP reduction seen after endurance training (131, 133). Lately there 
has been growing literature suggesting a relation between intensity and PEH (133-135). 
One recent study by Pescatello and Eicher et al demonstrates that training sessions 
performed near 100% of VO2max provides the largest BP reduction in hypertensive 
patients compared to training at lower intensities (133). Their results are in accordance to 
our results, showing a reduction of systolic ABP by 11.0 mmHg.  
 
Chronic effects of exercise on blood pressure 
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The exercise induced BP regulation is complex and a variety of mechanisms have been 
observed with aerobic endurance training. This include changes of the autonomic nervous 
system, circulating catecholamine’s, endothelial function, blood lipids, blood volume, 
total peripheral resistance, renin-angiotensin system and insulin resistance (55).   
 
The autonomic nervous system plays a central role in the hypertensive pathology. 
Exercise has been shown to reduce sympathetic nerve activity as shown by reduced 
circulating catecholamines (54), reduced activity in the postganglionic nerve activity 
from the peroneal nerve measured by microneurography (136). These studies 
areconsistent with our findings with reduced resting HR and increased HRR after 
maximal exercise.  
 
HR recovery after an exercise test is proven to be an index of the inhibitory effect on the  
vagal reactivation in the heart after the termination of the sympathetically activated state 
of exercise (118). Reduced HR after exercise is in accordance to many other studies (55, 
136, 137) suggesting an increased vagal tone and a reduced sympathetic drive (138). HR 
at rest and HR recovery after exercise testing are used as prognostic markers for CVD 
and mortality (32). In our study, however, the effect on HR recovery and HRmean was 
limited to the AIT group. The mechanisms behind the modulation of the autonomic 
nervous system may be multiple. Blood volume has been shown to increase in response 
to exercise training (139) and is believed to stimulate baroreceptors in the right atrium 
(130) which subsequently lead to a reduced sympathetic vasomotor tone(140). 
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Several studies have demonstrated a reduction of the plasma renin activity after exercise 
(55). In addition to reduced vasomotor tone, this may cause structural changes in the 
vasculature, since angiotensin II has a trophic effect on the smooth musculature. Trained 
subjects have an increased ratio of capillary lumen to intima media (141). In conclusion, 
this would contribute to a reduced TPR as seen in paper one.  
 
The hypertensive pathology leads to endothelial dysfunction with increased risk of 
thrombosis, cell proliferation of intima and smooth muscles and changes in the 
coagulation-fibrinolytic pathways. Several studies have demonstrated increased FMD and 
improved endothelial function after aerobic exercise in patients with CVD, including 
patients with hypertension, dyslipidemia and diabetes type II (142-144). High intensity 
aerobic interval training has shown in some studies to improve FMD and endothelial 
function more than exercising at lower intensities (76, 79), but the effect has been equal 
in other studies (145, 146) . In our study, endothelial function improved only in the AIT 
group. We have no explanation to the lack of improvement of FMD in the MIT group, 
which was unexpected. Although we did not measure FMD in paper two, regular aerobic 
exercise appears to slow down the age-related progression of central artery stiffening 
(144). There has been growing literature proving that high intensity training improves 
blood lipids more than training at lower intensities (12, 79, 147). In our study, only the 
AIT group improved Hdl cholesterol.  
 
The implications of AIT as treatment for patients with hypertension might be considered 
to be of clinical importance. Only small reductions of blood pressure have substantial 
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effects on morbidity and mortality of CVD. It has been estimated that a 2-mm Hg 
reduction of SBP results in a 6% reduction in stroke mortality and a 4% reduction in 
mortality attributable to coronary heart disease. For a 5-mmHg decrease of systolic BP 
the reduction in stroke and ischemic heart mortality was 14% and 9%, respectively (148). 
   
An effective method to increase aerobic capacity  
 
In all three studies AIT increased VO2max profoundly. In study one AIT improved VO2max 
more than MIT (15.0% vs 5.0%, group difference p<0.01). Our results are in line with 
other studies (75, 76, 79, 117, 149) reflecting the importance of intensity to increase 
VO2max. In paper one the AIT group increased VO2max by 0.15 ml/kg/min or 0.42% per 
training session. Large epidemiological studies show that higher levels of physical 
activity and physical fitness are associated with a continuous and graded reduction in the 
incidence of hypertension. Training at high intensity should therefore be efficient, not 
only to treat hypertension as seen in paper one, but also to prevent development of 
hypertension among healthy subjects. Physical activity is generally low in western 
countries and the incidence of hypertension is estimated to increase in the future. Aerobic 
capacity is a strong predictor of morbidity and mortality in healthy people and patients 
with CVD (11) and patients with hypertension (150). The results in paper one suggest 
that high intensity aerobic interval training is an effective approach to increase aerobic 
capacity and to reduce overall cardiovascular risk in hypertensive patients. 
 
Demographic patterns are changing in western countries, with a pattern of increased life 
expectancy and a reduced birth rate. The need of self-reliant among elderly is 
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importunate, and physical activity is a key element to achieve successful aging (151). 
During ageing there is a marked reduction of physical activity in leisure time, and 
especially high intensity exercises. Changes in behaviour to include more physical 
activity, and especially to include physical activity at higher intensities has shown to 
reduce the risk for future CVD events and increase longevity (152). A recent study by 
Kokkinos et al showed that aerobic fitness is a strong predictor of mortality also in a 
population of healthy older men (14). In paper two, the baseline value of VO2max among 
the seniors was 32.5 ml/kg/min, which is higher than an average value in the normal 
population for this age class (21). The AIT method increased VO2max in healthy seniors 
by 0.13 ml/kg/min per training session (a total of 14.0%) and is considerable taken the 
high baseline values into account. The effect of a vigorous training program in elderly 
people has been shown earlier, and our results are consistent with previous work (153). In 
our study, the compliance to the training program was high and suggests that AIT is a 
well tolerated training method among elderly healthy subjects.  
 
In paper three we observed a similar increase of VO2max in the moderate frequency group, 
with an average increase by 0.23 ml/kg/min per training session. The increase in the high 
frequency group was smaller, however not significant different from the moderate 
frequency group, with an average increase by 0.13 ml/kg/min (between group difference 
p=0.32). Immediately after terminating the training program we observed a non-
significant decline in VO2max in the HF group. This may suggest a lack of compensatory 
response due to a fatigue. Whether this fatigue was muscular, cardiopulmonary or central 
nervous is unclear. The subjects in the HF group were not able to achieve their HRmax and 
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felt exhausted and complained about a general fatigue throughout the training period and 
especially at the end of the training period. During the detraining period where sufficient 
restitution was obtained, we observed an increased VO2max in the HF group with their 
peak 12 days after terminating the training program.  
 
Our results suggest that improved VO2max among healthy non-exercising subjects is 
similar (relative change), regardless of age and training status. In addition, the 
improvements may be independent of the length of the training programme. Our results 
suggest that it is the numbers of training sessions that are of importance. However, our 
sample sizes in the different studies are limited by small sample sizes and of short 
duration.  
 
In paper three, the MF group improved VO2max almost double of what the HF group did, 
although not significantly different. We believe that longer duration of the training 
programme or a larger sample size, a significant difference would have occurred between 
the two groups. This is further supported by the initial reduction in the myocardial 
function and lung diffusion capacity seen in the high frequency group immediately after 
the training period. We would therefore suggest that the high frequency training is not 
advisable to untrained subjects.  
 
An effective method to improve myocardial function 
Regular aerobic endurance training induces several functional and structural changes in 
the heart muscle, characterized by increased LV cavity size and mass, referred to as the 
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athlete’s heart (154). This was first described in 1897 by Henschen, a Swedish physician, 
by percussion of the thorax of cross-country skiers. He observed an enlargement of the 
heart and stated that “Skiing causing an enlargement of the heart which can perform more 
work than the normal heart”. Cross sectional studies demonstrate that endurance trained 
athletes have larger LV cavities  and increased LV mass (154). Longitudinal studies of 
sedentary people starting aerobic endurance training support that myocardial changes 
occur in response to training (154-156). In all our three studies we confirm the same 
findings. Table 5 summarizes the effect of aerobic endurance training on myocardial 
function in our studies. 
 
Table 5. Echocardiography, effect of exercise 
 Hypertensive 
AIT 
Hypertensive 
MIT 
Seniors MF after 
training 
HF after 
training 
MF after 
detraining 
HF after 
detraining 
EDV, ml ↑ → ↑ ↑ ↑ → ↑ 
SV, ml ↑ → ↑ ↑ → → ↑ 
EF, % ↑ → ↑ ↑ ↓ → → 
E/A, ratio → → ↑ → → → → 
IVRT, ms ↓ → ↓ ↓ ↓ → ↑ 
e’, cm/s ↑ → ↑ → → → → 
S’, cm/s ↑ ↑ ↑ ↑ → →/↑ → 
e’exercise, 
cm/s 
   ↑ ↑ ↑ → → 
S’exercise, 
cm/s 
   ↑ ↑ ↑ → ↑ 
HRrest, ↓ → ↓ → ↓ → → 
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b/min 
HRmax, 
b/min 
→ → → ↓ ↓ → → 
  
EDV; end diastolic volume, SV; stroke volume, EF; ejection fraction, E/A; ratio of early 
diastolic mitral inflow velocity/late diastolic mitral inflow, IVRT; isovolumic relaxation 
time, e’; early diastolic tissue velocity measured at rest, S’; systolic tissue velocity 
measured at rest, e’exercise; early diastolic tissue velocity measured during exercise, 
S’exercise; systolic tissue velocity measured during exercise, , HRrest; Heart rate measured 
at rest during echocardiographic examination, HRmax; Maximal heart rate measured 
during maximal oxygen uptake test.  
  
In paper one AIT had a superior effect to increase myocardial systolic function compared 
to training at lower intensity. The positive effect of high intensity exercise on myocardial 
function in other CVD has been well documented in previous studies (76, 78, 119), but 
this is, to our knowledge, the first time it has been studied in a hypertensive population. 
Our study demonstrated increased stroke volume, end diastolic volume and ejection 
fraction in the AIT group. This is in accordance with the findings in paper two among the 
sedentary seniors and in paper three in the MF group. The effect on cardiac systolic 
performance correspond to earlier studies in aged populations (157). However, increased 
circulating blood volume in response to endurance training has earlier been reported after 
endurance training (139), and the effect is similar between moderate intensity continuous 
training and high intensity interval training (158). Increased EDV with a simultaneous 
increased SV, without increased LV wall thickness may thus reflect eccentric remodeling 
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as a response to training. In the high frequency group in paper three, EDV increased after 
the training period while resting SV was unchanged and EF was thus reduced. Systolic 
function measured by S’ increased at rest in the MF group, while no difference was 
observed in the HF group. The number of participants in this study is limited and the SV 
and S’ is similar in both groups after the training intervention. The baseline differences 
may be a question of coincidence, and a type 2 error can not be ruled out. On the other 
hand, we observed a reduced lung diffusion capacity and a small and non-significant 
decline in VO2max in this group.  This may indicate a temporary cardiopulmonary 
depression induced by the strenuous training program as been demonstrated before (159). 
After the detraining period (9 weeks), the increased EDV was sustained and SV had 
increased and EF was normalized to baseline value. This suggests that the restitution was 
inadequate and more rest was needed to induce compensatory cardiac adaptations, but 
that the cardiac effect was maintained for a longer time. The differences might have been 
more profound earlier in the detraining period, but can not be ruled out since the first 
measurements were initiated 8 weeks after termination of the training.  
 
In paper one, the changes in systolic tissue Doppler measurements were highly 
significant, while only borderline in the MIT group. There was a trend towards increased 
S’ in the MF group in paper three, but not among the seniors or the HF group in paper 
two and three. S’ is a relatively early event in systole and has been shown to correlate to 
contractility (160). However, S’ is inversely related to afterload (104) and correlates to 
HR (99). The population in paper one was hypertensive patients and both training groups 
reduced systolic BP and TPR which may have contributed to the increased S’. Among the 
68 
 
seniors we also observed a reduction in afterload, with unchanged  resting S’, but the 
effect on S’ may have been counteracted by a significant reduction in resting HR.. 
Nevertheless, S’ measured during exercise increased significantly in this group despite 
similar BP measurements during exercise. This may indicate an increased systolic 
function and an increased cardiac reserve independently of different loading conditions. 
Animal studies performed at our laboratory have reported incremental effect on 
contractility in isolated myocytes from rats after AIT compared to MIT. This supports an 
enhanced systolic function per se after AIT (161), not only improvement due to reduced 
load. However, increased plasma volume in response to training may have inferred our 
measurements and contributed to greater utilization of the Frank Starling effect  which 
may have increased S’ during exercise.  
 
Additional information, not sent for publication; In the HF group in paper three, we 
observed a reduced S’ measured during exercise after the training period, but this 
normalized after the detraining and tended to increase compared to baseline values, 
although not significantly (p=0.09). During exercise measurements, systolic BP and HR 
was similar in the HF group at baseline and follow up, which may indicate that there was 
a myocardial effect per se and not only an effect of different loading conditions.   
 
In conclusion our studies indicate that AIT enhances systolic cardiac performance in 
hypertensive patients as well as healthy aged and young subjects.  
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Diastolic function, measured by echocardiography, improved among the AIT group in 
paper one and among seniors in paper two, but not among any of the young subjects in 
paper three. Young sedentary subjects have a normal diastolic function, which is capable 
to meet increased physical demands (162, 163). Thus it is less probable that this increases 
with training.  
 
A normal diastolic function allows the LV to fill without increasing the filling pressure. 
Diastolic dysfunction refers to increased filling pressures, and is a common finding in 
hypertension, but the population in paper one was within the normal range when indexed 
for age (99, 164). However, we did not perform stress echocardiography testing in paper 
one, which may have unmasked diastolic abnormalities during exercise despite a normal 
diastolic function at rest. In a recent study, Tan et al demonstrated that subjects with well- 
monitored essential hypertension and absence of LVH had diastolic dysfunction during 
exercise, despite a normal diastolic function at rest (165). As for hypertension, aging 
causes changes in the diastolic function with increased left ventricular stiffness, fibrosis 
and reduced calsium handling in the cardiomyocytes (166). Tissue Doppler velocities are 
markedly reduced during aging, and e’ is reduced by 1 cm/second each decade after the 
age of 30 years (167). The aged myocardium contains less myocytes that are slightly 
increased in size, and in the extracellular matrix there is increased connective tissue due 
to degradation of matrix proteins (127). In paper two, the sedentary seniors had a mean 
value of e’ by 6.9 cm/second which is comparable to their age class in normal studies 
(99). Although debated, e’ is demonstrated to be useful as a less load dependent measure 
of left ventricular relaxation rate compared to traditional flow parameters (168). E’ 
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corresponds to tau, the rate constant of pressure versus time (dP/dT) in the LV 
isovolumic relaxation. The shortened IVRT among the AIT group in paper one and the 
seniors in paper two after AIT supports the finding of improved LV relaxation. The LV 
relaxation is, on the molecular level, determined by the rate of calcium reuptake in to the 
sarcoplasmatic reticulum by the sarcoplasmatic reticulum calcium ATPase (SERCA2). 
Animal studies have shown that calcium handling and SERCA2 activity are increased in 
older sedentary animals after participating in exercise programs (169-171). Increased 
relaxation rate with exercise is also demonstrated in isolated myocytes, thus showing that 
there are myocardial effects, not only effects due to reduced load (172) The mechanism 
for the improved e’ in our studies may be similar.  
 
Improved diastolic function among highly trained elderly subjects compared to sedentary 
controls has previously been demonstrated (173, 174). The improvement has been 
modest, and remains far below values observed in young sedate persons. An important 
drawback with echocardiographic measurements is that their values are a result of mixed 
influences of relaxation, stiffness and filling pressures. Levine et al has earlier proposed 
that lifelong endurance training improves LV compliance and not LV relaxation (174). 
LV compliance is a measure of change in volume over the change in pressure (dV/dP) 
and is the reciprocal of LV stiffness. LV compliance is determined by myocardial 
viscoelastic properties and ventricular-arterial coupling. LV compliance is measured 
correct by invasive LV pressure-volume loops, and is measured as the LV end diastolic 
pressure volume relation. Thus, reduced compliance is less relevant for the rate of early 
relaxation. However, in a recent study, Levine et al also found improved LV relaxation 
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after training intervention among sedate seniors (175). In this study, 9 sedentary men 
(70.6±3 years, 6 men, 3 women) exercise regularly for one year and progressively 
increased intensity and duration during the training period. Their results were compared 
to old Master Athletes (MA). Concordant to our study they found improved E/A ratio and 
a shortened IVRT after the training period, but conversely they found reduction of e’, 
which also differed from their other echocardiographic measurements. They speculate if 
their contradictory results show that LV relaxation did not actually improve, and that 
Doppler flow measurements increased only due to plasma volume expansion after 
training. Invasive measurements in the same study demonstrated that LV compliance did 
not improve after one year of training. On the other hand, our study revealed clear and 
concordant results for both flow and tissue Doppler measurements. Both early and late 
diastolic filling improved in our study. Both studies are small, and the differences may be 
explained by the differences between the groups.  
 
In paper one and two we found improved e’ and IVRT after the training intervention. 
This has previously been demonstrated (76, 119) and supports the beneficial effect of 
AIT on diastolic function. In addition, systolic BP decreased during the training period 
and thus reduced the afterload among the hypertensive patients and the seniors. The LV 
diastolic function is not isolated from the systolic function as LV recoil is affected. This 
is not only seen as a change in LV stiffness, but also the amount of systolic contraction, 
which again is afterload dependent. Arterial compliance is known to increase after 
training interventions (176). A reduced afterload causes less resistance to the systolic 
contraction, increasing the total amount, causing more recoil and a greater diastolic 
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suction. Heart rate has a significant influence on the traditional diastolic flow markers 
and may be partly responsible for the increased E/A ratio of the mitral flow (177) seen in 
our studies. Although tissue Doppler velocities have shown to be less dependent by HR 
(100), a recent study suggest that e’ is also affected by HR (101) which may have 
contributed to the increased e’ measured at rest among the seniors in paper two.  
 
During exercise the increased CO, which can increase as much as eight times from rest to 
maximal exercise (21), must be matched by enhanced LV diastolic filling. The need for 
an optimal diastolic function is thus crucial.  The filling time of the LV has to be reduced 
to match the increased HR. Filling time decreases from ~ 0.55 sec at a HR of 70 beats per 
minute to about 0.12 sec at a HR at 195 beats per minute (108, 178). In a recent study it 
was suggested that the key difference between sedentary seniors and Master athletes 
during submaximal exercise was the ability to augment the diastolic suction of the left 
ventricle (179). In paper two, we measured diastolic performance during stress with color 
tissue Doppler measurements of e’ and a’. Unfortunately, we measured e’ and a’ together 
(fusion) and not separately, which makes it difficult to differentiate between early active 
relaxation and static compliance. This is a limitation since we are not able to distinguish 
between the two measurements and thus unable to draw any conclusion of the early 
relaxation of the LV. 
 
The measurements before and after the training period were obtained at the same 
intensity and are nonetheless a measure of the diastolic function. Likewise, the results are 
in line with our other echocardiographic measurements. Among the seniors the diastolic 
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tissue Doppler velocity increased significantly (12.9±1.9 cm/s to 14.3±2.2 cm/s, p<0.01) 
and was different from the MA at baseline, but not after the training period (14.4±1.4 
cm/s, p<0.01 at baseline and p>0.90 at follow up). This indicates that cardiac diastolic 
reserve is trainable and that only three months of high intensity interval training may 
equalise life long endurance training in some subjects. However, the difference in 
diastolic function was larger between MA and young subjects than seniors and MA.  
 
Several cross sectional studies have observed an enhanced diastolic function among 
endurance trained individuals compared to sedentary controls (162), whilst some studies 
have not seen any differences (162). In longitudinal studies there exists limited data of 
alterations in diastolic function after training interventions. One study have shown that 
exercise capacity is closely linked to diastolic function (107). Based on our studies, it is 
not possible to determine the most important component to improve VO2max as both 
systolic and diastolic properties increased simultaneously after AIT. Our studies were not 
designed to elucidate the mechanisms behind the improved diastolic function. Further 
studies are required to answer this question.  
 
In conclusion our studies indicate that AIT enhances diastolic cardiac performance in 
hypertensive patients and healthy aged sedentary subjects, where diastolic function is 
reduced at the outset. The latter group, however, only to the level of trained counterparts 
of the same age, is far below the level of young subjects. Where diastolic function is 
absolutely normal, as in the young subjects, there is less effect of training.  
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Limitations and future directions of studies 
The main limitation in all training studies is that the studies primarily recruits the subjects 
most motivated for training. The potential of training as treatment is thus limited in the 
general population. 
 
Paper 1 
The patients in study 1 were recruited locally by an advertisement in the regional 
newspaper, Adresseavisen. This may potentially have resulted a selection bias as 
mentioned above, but our population is comparable to other, larger trials (54).   
 
This small study have to be considered as experimental and as an example of what is 
possible to achieve in an optimal laboratory setting, measuring only the physiological 
effects of training. The effect of AIT as treatment is dependent on factors such as how 
applicable the training regimen is in a multi-center setting, the number of patients it is 
possible to recruit, compliance and, the adherence to training as permanent lifestyle after 
the first intervention. Our study lacks long time follow-up data on the patients. Another 
limitation is the impossibility to blind the patients in regard to the training method and 
intensity. Psychological factors affect blood pressure and knowledge of the training 
intensity may have influenced the results, especially in the control group. Finally, we 
cannot completely rule out the possibility that some patients took blood pressure 
medication during the intervention period.  
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The strengths of the study is the strict training program which is easy to monitor, 
allowing the study of the physiological effects of the training interventions, and measure 
the progression according to any improvement in aerobic capacity.  
 
In a future setting, a multicenter study should be performed in order to validate the 
reproducibility of results at different centers, as well as larger number to do intention-to-
treat. As the long term adherence to training may be influenced by the degree of fitness 
improvement, long term follow up should be done to see if different training regimens 
might result in different adherence. Also, more focus should be emphasized on the drop-
outs to identify factors and distinguish between those subjects achieving a successful or 
unsuccessful training period. To reveal more of the antihypertensive mechanisms 
investigators should consider measurements of the sympathetic nervous system, heart rate 
variability, renin, vascular stiffness (tonometry) and blood volume. In addition, 
measurements of physical activity outside the study and dietary registrations should be 
easily obtained by validated questionnaires. 
 
Paper 2 
The group of healthy seniors consisted of highly motivated and healthy persons and does 
not represent the general population >70 years. This has to be kept in mind as the 
translation to the general population may not be transferable.   
 
The study is limited by its small number of participants and has a skew gender allocation 
in both the intervention group and among the master athletes. The seniors recruited to our 
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study were free of diseases, motivated and had a very high baseline VO2max. Our results 
may therefore not be transferable to the general age related population. Future 
recommendations to studies would include long term follow-up, recruit more patients 
from other patient populations and consider measurements of endothelial function, ABP, 
blood volume and artery stiffness.   
 
Paper 3 
The main limitation is the limited number of participants which affects the power of the 
secondary outcome measurements. In addition, in our study we observed inadequate 
restitution, but with a modification of the exercise design allowing more days without 
training, the results may have been different. Future studies should search to identify an 
“overtraining factor” and a “restitution factor” that may lead to an individual tailored 
advice for athletes to achieve an optimal progression of training adaptations.  
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